Drug class
First-generation H1 antihistamine; piperazine-derived antiallergic agent
Mechanism of action
Antagonises histamine H1 receptors and has central sedative and anticholinergic effects. These actions reduce histamine-mediated allergic symptoms and can suppress vestibular nausea and motion sickness.
General use cases
- Relief of allergic symptoms and prevention or treatment of motion sickness in countries where moxastine-containing products are authorised.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
